5-Bromo-2,3-dihydrospiro[indene-1,3'-pyrrolidine]-2',5'-dione

Catalog No. :
ACJQUO096
CAS No. :
956141-85-8
Molecular Formula :
C12H10BrNO2
Molecular Weight :
280.12

IUPAC Name:5-bromo-2,3-dihydrospiro[indene-1,3'-pyrrolidine]-2',5'-dione

5-Bromo-2,3-dihydrospiro[indene-1,3'-pyrrolidine]-2',5'-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$282.00Login to see priceInquiryInquiry
100mg95%$414.00Login to see priceInquiryInquiry
250mg95%$581.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2,3-dihydrospiro[indene-1,3'-pyrrolidine]-2',5'-dione
IUPAC Name5-bromo-2,3-dihydrospiro[indene-1,3'-pyrrolidine]-2',5'-dione
MDL No.MFCD24149434
Molecular FormulaC12H10BrNO2
Molecular Weight280.12
SMILESO=C(C12CCC3=C1C=CC(Br)=C3)NC(C2)=O
InChI KeyZSEXZGPBZMYCND-UHFFFAOYSA-N
Synonym5-Bromo-2,3-dihydrospiro[indene-1,3'-pyrrolidine]-2',5'-dione;Spiro[1H-indene-1,3'-pyrrolidine]-2',5'-dione, 5-bromo-2,3-dihydro-
CAS No.956141-85-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACJQUO096 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACBFSC511 route compound structure diagram
    ACBFSC51143086-58-4
  6. Then
  7. ACJQUO096 route product structure diagram
    ACJQUO096956141-85-8
Inquiry

2. ACJQUO096 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJQUO096 route product structure diagram
    ACJQUO096956141-85-8
Inquiry

Comments (0)